Japan's Otsuka Plans Drug M&As With $1.9 Billion In IPO Gains
This article was originally published in PharmAsia News
Executive Summary
Otsuka Holdings of Japan plans to use proceeds of its $1.9 billion initial public offering on mergers and acquisitions of new drugs, its president said